bioRxivMicrobiology
Crystal structure of monkeypox H1 phosphatase, an Antiviral Drug Target
W. Cui, H. Huang, Y. Duan, Z. Luo, H. Wang, T. Zhang, H. Nguyen, W. Shen, D. Su, X. Ji, H. Yang, W. Wang
Abstract
The current monkeypox outbreak has caused over 64,000 global cases, but the effective treatments are very limited. The dual specific phosphatase (H1) from monkeypox antagonizes the immune response and is crucial for viral replication, making it an attractive antiviral target. Here we determined a 1.8-[A] crystal structure of H1, which forms a domain swapped dimer resembling a butterfly. Each active site, which consists of a Cys-Arg-Asp triad, captures a phosphate ion. The observed conformation mimics the final step of catalysis prior to product release. The crystal structure provides a strong foundation for the discovery of new antivirals against this emerging worldwide pathogen.
- organism: virus
- assay: protein structure
- research focus: protein structure prediction
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Crystal structure of mRNA cap (guanine-N7) methyltransferase E12 subunit from monkeypox virus and discovery of its inhibitors
D.-P. Wang, R. Zhao, … X. Zhou·bioRxiv·Mar 12, 2023
- Structural basis for the assembly of the DNA polymerase holoenzyme from a monkeypox virus variant
- Identification of inosine monophosphate dehydrogenase as a potential target for anti-monkeypox virus agents
T. Hishiki, T. Morita, … K. Watashi·bioRxiv·Dec 26, 2022
- Peptide recognition and dephosphorylation by the vaccinia VH1 phosphatase
B. Zhao, M. Hogan, … R. G. Ulrich·bioRxiv·May 26, 2020
- Discovery of a Heparan Sulfate Binding Domain in Monkeypox Virus H3 as an Anti-poxviral Drug Target Combining AI and MD Simulations
Bin Zheng, Meimei Duan, … Peng Zheng·eLifePeer-reviewed·Aug 13, 2024
- The structure of monkeypox virus 2'-O-ribose methyltransferase VP39 in complex with sinefungin provides the foundation for inhibitor design